Siloxon 1 TZ Injection
By Siloxon TZ
Rx
1 Injection in a Vial

Composition
Ceftriaxone(1000mg) + Tazobactum(125mg)

Manufacturer - Silicon Pharma
B-18, Galaxy Signature, Opp. Shukan Bunglows, Science City Road, Ahmedabad-380060. (Guj.)

Expires on or after
October, 2025

liver
When using Siloxon 1 TZ Injection, it's important to be cautious if you have severe liver disease. In such cases, the dosage of Siloxon 1 TZ Injection may need to be adjusted. It's crucial to consult your doctor before starting treatment with Siloxon 1 TZ Injection if you have severe liver disease. However, if you have mild to moderate liver disease, dose adjustment of Siloxon 1 TZ Injection is not typically recommended. Always follow your doctor's guidance and advice regarding the use of Siloxon 1 TZ Injection in relation to your liver health.

kidney
Limited data exists on the use of Siloxon 1 TZ Injection in people with kidney issues. It's recommended to seek advice from your doctor.

alcohol
When taking Siloxon 1 TZ Injection, it is safe to consume alcohol as it does not lead to any harmful effects.

driving
Siloxon 1 TZ Injection may reduce alertness and cause drowsiness or dizziness. It is advised not to drive if experiencing these symptoms.

pregnancy
Siloxon 1 TZ Injection is generally safe during pregnancy. Animal studies show minimal harm to the baby, but human studies are limited.

breastfeeding
Siloxon 1 TZ Injection should be used cautiously while breastfeeding. It is advised to temporarily stop breastfeeding until the mother's treatment is finished and the medicine is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹152
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024